Clinical Trial Update: Docetaxel in Treating Patients With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating docetaxel for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED